Stock Track | QuidelOrtho Soars 9.79% After-Hours on Stellar Q2 Earnings Beat

Stock Track

Aug 06, 2025

QuidelOrtho (NASDAQ: QDEL) shares surged 9.79% in after-hours trading on Tuesday, following the release of the company's second-quarter 2025 financial results that significantly exceeded analyst expectations. The diagnostic healthcare product manufacturer demonstrated strong performance despite challenging market conditions.

The company reported an adjusted earnings per share (EPS) of $0.12, dramatically outperforming the analyst consensus estimate of $0.01. This represents a remarkable 1400% beat and a 271.43% increase from the same period last year when the company posted a loss of $0.07 per share. QuidelOrtho's revenue for the quarter came in at $613.9 million, surpassing the analyst estimate of $609.978 million by 0.64%. However, it's worth noting that this figure represents a 3.63% decrease from the $637 million reported in the same quarter of the previous year.

Despite the slight year-over-year revenue decline, investors appear to be focusing on QuidelOrtho's ability to exceed expectations and improve profitability. The company also reiterated its full-year 2025 financial guidance, suggesting confidence in its future performance. The strong after-hours stock movement indicates that market participants are reacting positively to QuidelOrtho's earnings beat and outlook, potentially seeing it as a sign of the company's resilience and growth potential in the competitive diagnostic healthcare sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1133977728"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133977728\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133977728?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-06 04:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133977728","market":"sg","top_or_hot":-1,"title":"Stock Track | QuidelOrtho Soars 9.79% After-Hours on Stellar Q2 Earnings Beat","media":"Stock Track","content":"<p>QuidelOrtho (NASDAQ: QDEL) shares surged 9.79% in after-hours trading on Tuesday, following the release of the company's second-quarter 2025 financial results that significantly exceeded analyst expectations. The diagnostic healthcare product manufacturer demonstrated strong performance despite challenging market conditions.</p>\n\n<p>The company reported an adjusted earnings per share (EPS) of $0.12, dramatically outperforming the analyst consensus estimate of $0.01. This represents a remarkable 1400% beat and a 271.43% increase from the same period last year when the company posted a loss of $0.07 per share. QuidelOrtho's revenue for the quarter came in at $613.9 million, surpassing the analyst estimate of $609.978 million by 0.64%. However, it's worth noting that this figure represents a 3.63% decrease from the $637 million reported in the same quarter of the previous year.</p>\n\n<p>Despite the slight year-over-year revenue decline, investors appear to be focusing on QuidelOrtho's ability to exceed expectations and improve profitability. The company also reiterated its full-year 2025 financial guidance, suggesting confidence in its future performance. The strong after-hours stock movement indicates that market participants are reacting positively to QuidelOrtho's earnings beat and outlook, potentially seeing it as a sign of the company's resilience and growth potential in the competitive diagnostic healthcare sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | QuidelOrtho Soars 9.79% After-Hours on Stellar Q2 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | QuidelOrtho Soars 9.79% After-Hours on Stellar Q2 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-06 04:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>QuidelOrtho (NASDAQ: QDEL) shares surged 9.79% in after-hours trading on Tuesday, following the release of the company's second-quarter 2025 financial results that significantly exceeded analyst expectations. The diagnostic healthcare product manufacturer demonstrated strong performance despite challenging market conditions.</p>\n\n<p>The company reported an adjusted earnings per share (EPS) of $0.12, dramatically outperforming the analyst consensus estimate of $0.01. This represents a remarkable 1400% beat and a 271.43% increase from the same period last year when the company posted a loss of $0.07 per share. QuidelOrtho's revenue for the quarter came in at $613.9 million, surpassing the analyst estimate of $609.978 million by 0.64%. However, it's worth noting that this figure represents a 3.63% decrease from the $637 million reported in the same quarter of the previous year.</p>\n\n<p>Despite the slight year-over-year revenue decline, investors appear to be focusing on QuidelOrtho's ability to exceed expectations and improve profitability. The company also reiterated its full-year 2025 financial guidance, suggesting confidence in its future performance. The strong after-hours stock movement indicates that market participants are reacting positively to QuidelOrtho's earnings beat and outlook, potentially seeing it as a sign of the company's resilience and growth potential in the competitive diagnostic healthcare sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QDEL","symbol_name":"窥得儿医药","start_time":0,"source_url":"","article_id":"1133977728","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133977728","pubTimestamp":1754426289,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"QuidelOrtho (NASDAQ: QDEL) shares surged 9.79% in after-hours trading on Tuesday, following the release of the company's second-quarter 2025 financial results that significantly exceeded analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QDEL":"窥得儿医药"},"translate_title":"股票追踪|QuidelOrtho因第二季度盈利出色而盘后飙升9.79%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QDEL":1},"content_text":"QuidelOrtho (NASDAQ: QDEL) shares surged 9.79% in after-hours trading on Tuesday, following the release of the company's second-quarter 2025 financial results that significantly exceeded analyst expectations. The diagnostic healthcare product manufacturer demonstrated strong performance despite challenging market conditions.\nThe company reported an adjusted earnings per share (EPS) of $0.12, dramatically outperforming the analyst consensus estimate of $0.01. This represents a remarkable 1400% beat and a 271.43% increase from the same period last year when the company posted a loss of $0.07 per share. QuidelOrtho's revenue for the quarter came in at $613.9 million, surpassing the analyst estimate of $609.978 million by 0.64%. However, it's worth noting that this figure represents a 3.63% decrease from the $637 million reported in the same quarter of the previous year.\nDespite the slight year-over-year revenue decline, investors appear to be focusing on QuidelOrtho's ability to exceed expectations and improve profitability. The company also reiterated its full-year 2025 financial guidance, suggesting confidence in its future performance. The strong after-hours stock movement indicates that market participants are reacting positively to QuidelOrtho's earnings beat and outlook, potentially seeing it as a sign of the company's resilience and growth potential in the competitive diagnostic healthcare sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}